Co-transformation of NPR1-BD + AD, BD + ATG6-AD, BD + SnRK2.8-AD, NPR1-N-BD + AD, and NPR1-C-BD + AD were used as negative controls. This evidence concerns the gene BECN1 and Alzheimer disease.